TY - JOUR
T1 - RISE-Vac—Co-Production of Vaccine Education Materials with Persons Persons Living in Prison
AU - Laryea-Adekimi, Femi
AU - D’Arcy, Jemima
AU - Bardelli, Angela
AU - Mieuset, Aurélie
AU - Busmachiu, Vlad
AU - Barbiros, Irina
AU - Meroueh, Fadi
AU - Doltu, Svetlana
AU - Walsh, Niall
AU - Harriott, Paula
AU - Tavoschi, Lara
AU - Plugge, Emma
AU - Roselló, Alicia
N1 - Publisher Copyright:
© 2024 Centers for Disease Control and Prevention (CDC). All rights reserved.
PY - 2024
Y1 - 2024
N2 - Increasing vaccination knowledge is effective in addressing hesitancy and is particularly important in populations deprived of liberty who may not routinely have access to health information, ensuring health equity. RISE-Vac is a European Union–funded project aiming to promote vaccine literacy, offer, and uptake in prisons in Europe. We consulted persons living in prisons in the United Kingdom (through the Prisoner Policy Network), France, and Moldova to determine their vaccination knowledge gaps, the information they would like to receive, and how they would like to receive it. We received 344 responses: 224 from the United Kingdom, 70 from France, and 50 from Moldova. Participants were particularly interested in learning about the effectiveness, side effects, and manufacturing of vaccines. Their responses guided the development of educational materials, including a brochure that will be piloted in prisons in Europe. Persons with experience of imprisonment were involved at every stage of this project.
AB - Increasing vaccination knowledge is effective in addressing hesitancy and is particularly important in populations deprived of liberty who may not routinely have access to health information, ensuring health equity. RISE-Vac is a European Union–funded project aiming to promote vaccine literacy, offer, and uptake in prisons in Europe. We consulted persons living in prisons in the United Kingdom (through the Prisoner Policy Network), France, and Moldova to determine their vaccination knowledge gaps, the information they would like to receive, and how they would like to receive it. We received 344 responses: 224 from the United Kingdom, 70 from France, and 50 from Moldova. Participants were particularly interested in learning about the effectiveness, side effects, and manufacturing of vaccines. Their responses guided the development of educational materials, including a brochure that will be piloted in prisons in Europe. Persons with experience of imprisonment were involved at every stage of this project.
UR - http://www.scopus.com/inward/record.url?scp=85189770413&partnerID=8YFLogxK
U2 - 10.3201/EID3013.230812
DO - 10.3201/EID3013.230812
M3 - Article
C2 - 38561865
AN - SCOPUS:85189770413
SN - 1080-6040
VL - 30
SP - S56-S61
JO - Emerging Infectious Diseases
JF - Emerging Infectious Diseases
IS - 13
ER -
